Zhejiang HISUN Biomaterials Co. Ltd. A (688203) - Total Liabilities

Latest as of June 2025: CN¥542.63 Million CNY ≈ $79.40 Million USD

Based on the latest financial reports, Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has total liabilities worth CN¥542.63 Million CNY (≈ $79.40 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Zhejiang HISUN Biomaterials Co. Ltd. A - Total Liabilities Trend (2020–2024)

This chart illustrates how Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Zhejiang HISUN Biomaterials Co. Ltd. A's working capital to evaluate short-term liquidity relative to the company's equity base.

Zhejiang HISUN Biomaterials Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Zhejiang HISUN Biomaterials Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Hunan Xiangjia Animal Husbandry Co
SHE:002982
China CN¥2.49 Billion
F-SECURE OYJ
HE:FSECURE
Finland €219.49 Million
Cadiz Inc
NASDAQ:CDZI
USA $117.66 Million
29METALS Ltd
AU:29M
Australia AU$595.63 Million
Wuhan Tianyu Info Industry
SHE:300205
China CN¥662.77 Million
China Western Power Industrial Co Ltd
SHE:002630
China CN¥8.67 Billion
Tesco PLC
LSE:TSCO
UK GBX28.02 Billion
Chengdu Dahongli Machinery Co Ltd
SHE:300865
China CN¥250.67 Million

Liability Composition Analysis (2020–2024)

This chart breaks down Zhejiang HISUN Biomaterials Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang HISUN Biomaterials Co. Ltd. A stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.69 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.37 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang HISUN Biomaterials Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)

The table below shows the annual total liabilities of Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥574.05 Million
≈ $84.00 Million
+0.84%
2023-12-31 CN¥569.25 Million
≈ $83.30 Million
+19.45%
2022-12-31 CN¥476.56 Million
≈ $69.74 Million
-9.96%
2021-12-31 CN¥529.26 Million
≈ $77.45 Million
-4.70%
2020-12-31 CN¥555.36 Million
≈ $81.27 Million
--

About Zhejiang HISUN Biomaterials Co. Ltd. A

SHG:688203 China Chemicals
Market Cap
$340.48 Million
CN¥2.33 Billion CNY
Market Cap Rank
#14319 Global
#4284 in China
Share Price
CN¥11.48
Change (1 day)
+0.17%
52-Week Range
CN¥10.95 - CN¥16.70
All Time High
CN¥20.59
About

Zhejiang Hisun Biomaterials Co.Ltd. engages in the research, development, production, and sale of polylactic acid in China. The company's products are used in various applications that include 3D printing, extrusion, thermoforming, film and laminating, injection molding, non-woven fabric, and injection blow molding. Zhejiang Hisun Biomaterials Co.Ltd. was founded in 2004 and is based in Taizhou, … Read more